ECLIPSE registrational program now fully underway, following enrollment of the first patient in ECLIPSE 3 ECLIPSE 3 is designed to compare the combination of tobevibart and elebsiran to bulevirtide in ...
An increasing number of people are finding trail running relatively late in life – and they’re reaping the health benefits Earlier this year, 62-year-old Karla Wagner placed second in the 100-mile ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results